November 30, 2015: BioAegis Therapeutics Receives NJ Emerging Technology & Life Science Incentive: $544,000 in Technology Business Tax Certificate Transfer Program

BOSTON, MASSACHUSSETTS and MORRISTOWN, NEW JERSEY–(BIOAEGIS THERAPEUTICS – November 30, 2015) BioAegis Therapeutics announces that it has sold a combination of net operating losses and R&D Credits totaling $544,000. The company’s application to this State of New Jersey’s Technology Business Tax Credit Transfer Program was previously accepted in June.